Bortezomib powder 1mg
Bortezomib powder 3.5mg
Browse Alphabetically:
A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #
Information about ExpressMedsCanada.com
List of countries where we can ship Bortezomib:
Latest news releases on Bortezomib:
(RTTNews) - CytRx Corp. (CYTR: News ) announced that in animal and in vitro studies, its tumor-targeting doxorubicin conjugate INNO-206 showed anti-multiple myeloma effects and enhanced the anti-tumor effects of bortezomib, which is approved for the ...
"We found that, in our mouse models of human myelomas, INNO-206 alone produced marked anti-multiple myeloma effects at a dose at which doxorubicin alone was extremely toxic, and the combination of INNO-206 and bortezomib produced increased anti-multiple ...
And the prod? CYTR has developed a doxorubicin conjugate (INNO-206) that has showed anti-multiple myeloma effects, as well as enhanced the anti-tumor effects of bortezomib. The efficacy of the combination isn't new; the results of Phase 1/2 trial were ...
About VELCADE ® (bortezomib) [3] VELCADE ® (bortezomib) is a first-in-class proteasome inhibitor approved in the EU for use in combination with melphalan and prednisone in previously untreated patients with multiple myeloma (i.e. the front line setting ...
The head-to-head trial will evaluate the combination of Kyprolis and low-dose dexamethasone vs. the combination of bortezomib and low-dose dexamethasone. A Phase 1/2 study being conducted by Onyx's partner Ono Pharmaceutical Co., Ltd is ...
Paul Richardson, MD, Clinical Director of the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute commented, "On behalf of my colleagues involved worldwide in the ongoing pivotal trial comparing bortezomib and dexamethasone alone to the ...